Earnings Call · Q1 FY2025·2025-05-13

Q1 25EPS +10.36%·Rev n/aQ4 24EPS +10.67%·Rev n/aQ3 24EPS +0.51%·Rev n/aQ2 24EPS +2.91%·Rev n/a⚠ consensus missing

Karyopharm Therapeutics Inc. KPTI

Brendan Strong — Investor Relations or Communications

Richard Paulson — Chief Executive Officer

Reshma Rangwala — Clinical/Medical Executive

Sohanya Cheng — Commercial/Marketing Executive

Lori Macomber — Chief Financial Officer

−20.0%1d on move date−20.7% vs SPY3d−11.5%5d−16.7%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more KPTI calls or request research access.

More KPTI calls Browse calls Request research access